29.23
price up icon0.58%   0.17
pre-market  Vorhandelsmarkt:  29.95   0.72   +2.46%
loading

Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten

pulisher
Feb 17, 2026

5-year MS study: BRIUMVI patients average one relapse every 50 years - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

Liquidity Mapping Around (TGTX) Price Events - Stock Traders Daily

Feb 16, 2026
pulisher
Feb 16, 2026

Portfolio Shifts: Should you avoid TG Therapeutics Inc stock right now2025 Investor Takeaways & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Feb 16, 2026
pulisher
Feb 16, 2026

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 55.89% Potential Upside in the Biotech Space - DirectorsTalk Interviews

Feb 16, 2026
pulisher
Feb 14, 2026

What are TG Therapeutics Inc.’s recent SEC filings showingMarket Performance Summary & Free Long-Term Investment Growth Plans - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

What are TG Therapeutics Inc.’s growth leversJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

TG Therapeutics, Inc. $TGTX Shares Bought by Public Sector Pension Investment Board - MarketBeat

Feb 14, 2026
pulisher
Feb 14, 2026

TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 14, 2026
pulisher
Feb 14, 2026

TG Therapeutics (NASDAQ:TGTX) Downgraded by Wall Street Zen to "Hold" - MarketBeat

Feb 14, 2026
pulisher
Feb 13, 2026

What is TG Therapeutics Inc.’s valuation compared to sectorJuly 2025 Opening Moves & Verified Momentum Stock Ideas - mfd.ru

Feb 13, 2026
pulisher
Feb 13, 2026

TGTX Stock Price, Forecast & Analysis | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill

Feb 13, 2026
pulisher
Feb 11, 2026

Goldman Sachs Raises TG Therapeutics, Inc. (TGTX) Target to $39 on 2026 Guidance - Insider Monkey

Feb 11, 2026
pulisher
Feb 11, 2026

TGTX News Today | Why did TG Therapeutics stock go down today? $TGTX - MarketBeat

Feb 11, 2026
pulisher
Feb 10, 2026

Should you avoid TG Therapeutics Inc. stock right now2025 Sector Review & Free Risk Controlled Daily Trade Plans - mfd.ru

Feb 10, 2026
pulisher
Feb 10, 2026

Why TG Therapeutics Inc. (NKB2) stock gets analyst attentionTrade Entry Report & Community Supported Trade Ideas - mfd.ru

Feb 10, 2026
pulisher
Feb 10, 2026

10 Best Long Term Healthcare Stocks to Buy - Insider Monkey

Feb 10, 2026
pulisher
Feb 10, 2026

TG Therapeutics (TGTX) sees price target drop from JPMorgan - MSN

Feb 10, 2026
pulisher
Feb 09, 2026

Should New BRIUMVI Data and MS Campaign Shift TG Therapeutics' (TGTX) Narrative on Commercial Execution? - Yahoo Finance

Feb 09, 2026
pulisher
Feb 09, 2026

TG Therapeutics lights up Super Bowl with Christina Applegate MS campaign — retail sees 'huge win' - MSN

Feb 09, 2026
pulisher
Feb 09, 2026

TG Therapeutics Lights Up Super Bowl With Christina Applegate MS Campaign — Retail Sees 'Huge Win' - Stocktwits

Feb 09, 2026
pulisher
Feb 09, 2026

MSFT Vs AMZN Vs GOOGL: Which Cloud Stock Is A Better Bet? - Stocktwits

Feb 09, 2026
pulisher
Feb 08, 2026

TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - GlobeNewswire

Feb 08, 2026
pulisher
Feb 08, 2026

Christina Applegate fronts new MS honesty campaign with TG Therapeutics - Stock Titan

Feb 08, 2026
pulisher
Feb 08, 2026

TG Therapeutics Partners with Christina Applegate to Raise MS Awareness - intellectia.ai

Feb 08, 2026
pulisher
Feb 07, 2026

TG Therapeutics (TGTX) Sees Price Target Drop from JPMorgan - Finviz

Feb 07, 2026
pulisher
Feb 06, 2026

TG Therapeutics presents BRIUMVI data at ACTRIMS forum By Investing.com - Investing.com Nigeria

Feb 06, 2026
pulisher
Feb 06, 2026

TG Therapeutics stock pops as Briumvi boom reignites bull case: Goldman Sachs sees room for 32% rally - MSN

Feb 06, 2026
pulisher
Feb 06, 2026

TG Therapeutics Presents BRIUMVI Data at ACTRIMS Annual Meeting - Intellectia AI

Feb 06, 2026
pulisher
Feb 06, 2026

TG Therapeutics presents BRIUMVI data at ACTRIMS forum - Investing.com

Feb 06, 2026
pulisher
Feb 06, 2026

TG Therapeutics rises on new data for autoimmune therapy - TradingView

Feb 06, 2026
pulisher
Feb 06, 2026

TG Therapeutics Presents New Data on BRIUMVI® at ACTRIMS 2026 Annual Forum - Quiver Quantitative

Feb 06, 2026
pulisher
Feb 06, 2026

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum - The Manila Times

Feb 06, 2026
pulisher
Feb 06, 2026

Real-world and pediatric MS data put BRIUMVI under spotlight at ACTRIMS - Stock Titan

Feb 06, 2026
pulisher
Feb 05, 2026

Aug Intraday: Is TG Therapeutics Inc a turnaround story2025 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 05, 2026

Why (TGTX) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Feb 05, 2026
pulisher
Feb 04, 2026

TG Therapeutics (NASDAQ:TGTX) Takes On Some Risk With Its Use Of Debt - 富途牛牛

Feb 04, 2026
pulisher
Feb 04, 2026

TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth - Investing.com Canada

Feb 04, 2026
pulisher
Feb 03, 2026

Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares - AOL.com

Feb 03, 2026
pulisher
Feb 02, 2026

JP Morgan Adjusts Price Target for TGTX, Maintains Overweight Ra - GuruFocus

Feb 02, 2026
pulisher
Feb 02, 2026

JPMorgan Chase & Co. Issues Pessimistic Forecast for TG Therapeutics (NASDAQ:TGTX) Stock Price - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring the 52.42% Potential Upside and Strategic Positioning in Biotechnology - DirectorsTalk Interviews

Feb 02, 2026
pulisher
Jan 31, 2026

Quarterly Trades: Will TG Therapeutics Inc benefit from AI trendsWeekly Gains Report & Fast Momentum Entry Tips - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 30, 2026

Universal Beteiligungs und Servicegesellschaft mbH Has $2.29 Million Stake in TG Therapeutics, Inc. $TGTX - MarketBeat

Jan 30, 2026
pulisher
Jan 27, 2026

TG Therapeutics Readies New BRIUMVI Data As Market Weighs Valuation - Sahm

Jan 27, 2026
pulisher
Jan 27, 2026

Assessing TG Therapeutics (TGTX) Valuation After Recent Share Price Weakness And BRIUMVI Growth Assumptions - Yahoo Finance

Jan 27, 2026
pulisher
Jan 27, 2026

TG Therapeutics to present BRIUMVI data at ACTRIMS forum By Investing.com - Investing.com Canada

Jan 27, 2026
$45.34
price down icon 0.15%
$27.48
price up icon 1.44%
$102.99
price up icon 1.81%
$107.95
price up icon 0.90%
$151.11
price up icon 0.39%
biotechnology ONC
$359.05
price up icon 1.18%
Kapitalisierung:     |  Volumen (24h):